[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Mercia Asset Management Plc LSE:MERC London Ordinary Share GB00BSL71W47 ORD 0.001P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 39.00 38.00 40.00 39.00 39.00 39.00 40,469 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 23.4 34.0 7.8 5.0 172

Mercia Asset Management Share Discussion Threads

Showing 976 to 998 of 1250 messages
Chat Pages: 50  49  48  47  46  45  44  43  42  41  40  39  Older
DateSubjectAuthorDiscuss
25/9/2020
09:06
I don’t think it is acceptable for Mercia to just state that all AGM items were duly passed. Shareholders should expect to see the numbers of votes for and against each item. https://otp.tools.investis.com/Utilities/PDFDownload.aspx?Newsid=1418402
jane deer
25/9/2020
08:57
Oxygen looks very good but ndreams could be even bigger.....either would double the share price if they were sold or floated.....as this would point up the potential in the rest of the portfolio. The management here have come in for criticism but they have done/are doing everything they said they would do........including investing in the company. As usual private investors have taken the share price as a reflection of management's effort/abilities and that is seldom the case.
pavey ark
25/9/2020
08:48
Just to add that, whilst I am an enthusiastic supporter of British technology/business etc, Oxgene's last reported revenues were apparently £2m after an 100% increase, which cooled my enthusiasm somewhat. I genuinely hope this all comes good for investors. Good luck all!
wan
25/9/2020
08:21
Agreed SEV. Mercia's life sciences holdings look very promising. I'm particularly interested in Oxgene.
columbarius
25/9/2020
07:51
Good to see five Directors adding further share purchases to their personal stakes in Mercia yesterday, including one for 1,200,000 shares at 20p. Very positive news. https://www.investegate.co.uk/mercia-asset-mgt-plc--merc-/rns/director-pdmr-dealings/202009250700030714A/
sev22
24/9/2020
19:07
https://uk.tradingview.com/symbols/LSE-MERC/technicals/
sev22
24/9/2020
16:32
Ok . Good!
robsy2
24/9/2020
15:08
I think you're mistaken Robsy2. £658m is in long term funds. Including the balance sheet, they manage c.£800m as announced with the finals and re-iterated today.
columbarius
24/9/2020
12:05
I thought there had been a change of thought when they all bought in recently... gave me hope but looks to be a false dawn D
dennisbergkamp
24/9/2020
08:49
I'm still in but have to agree about management and am considering options. I hope I'm wrong, often am, but if not that something changes.
p1nkfish
24/9/2020
08:39
I'm out. Deciding, amongst other things, including past events, that the management are so far up their own backsides and those of the fund managers, that private investors, are at best, an irritant. Should Mercia really be listed? Perhaps that creates opportunity, but I cannot wait any longer when decent opportunity is available elsewhere, opportunity with a degree of clarity that seems to escape Mercia (perhaps that's intentional?).
wan
24/9/2020
08:01
There is bound to be a fall in value of FUM along with the wider market - it should recover once gov.uk gets some sense.
weatherman
24/9/2020
07:18
At year end 31.03.20 they had 800m of funds under management now it is 658m. I suppose that reduces their fee income accordingly.
robsy2
23/9/2020
13:00
Thanks for spotting those announcements and providing the links columbarius
srichardson8
22/9/2020
21:16
Certainly will be dilution over time.
p1nkfish
22/9/2020
20:27
I am afraid that Mercia is a pit that swallows money voraciously. There are no returns for the shareholders, who have been tapped more than once. The returns on these 'stellar investments' are less than mediocre, if and when they arise. Directors on an ego trip, with stupid remuneration and a bottomless pit of expenses as they swan around in the pomp of their self importance.
redartbmud
22/9/2020
19:34
PinkF, You’re right about merc... no matter how much great news from their investees, the price just goes backwards! Here’s to hoping for a lasting blue... D
dennisbergkamp
22/9/2020
18:43
Good news released by two of Mercia’s portfolio life science companies - Oxgene and Locate Bio. hTtps://www.oxgene.com/News-and-Events/News/2020/09/TESSA-Technology-Launch hTtps://www.locatebio.com/locate-bio-acquires-complementary-late-stage-orthobiologics-assets/
columbarius
21/9/2020
15:19
Mercia launches debt fund with up to £40m to invest (21st September 2020). Mercia is continuing its support of UK SMEs with an additional commitment to its debt funds. Over the next five years, Mercia will provide up to £40million to support the growth of regional SMEs across the UK. Mercia SME Loans will be providing a much-needed source of finance to ambitious, regional businesses that are seeking debt finance as they move beyond the cash flow constrains caused by the COVID-19 pandemic. Mercia’s investment team can lend between £100,000 to £1million to fund working capital, acquisitions, capital investment and management team restructures/buyouts, an area of specialism for Mercia. The fund can invest in all areas of the UK with a focus on the North of England. Mercia SME Loans is backed by existing investor, Greater Manchester Pension Fund. It builds on earlier investments completed into previous debt and private equity funds in a relationship which spans more than 15 years. Mercia’s first SME Loans fund launched in 2015 and backed 52 businesses including high profile brands such as Harrogate Spring Water and polyeurathane fabricators, Rosehill Polymers. MD of Mercia Debt Funds, Paul Taberner explained: “Mercia SME Loans backs profitable and ambitious SMEs that are reigniting growth plans stalled during the first part of this year. We’re already seeing a strong pipeline of new deals as the regional economies start to recover and we hope initiatives like the launch of our new fund will stimulate even more growth as the country fights back to recovery.”
sev22
18/9/2020
10:49
Firm raises £1m for ‘smart bearings’ that detect wear and tear (18th September 2020). A Sheffield company whose smart sensing technology helps industry to reduce costs has raised £1.1m from NPIF – Mercia Equity Finance, which is managed by Mercia and is part of the Northern Powerhouse Investment Fund. Tribosonics embeds sensors within bearings and other moving parts to create ‘intelligent components’ which can monitor friction and wear and tear. The results help companies to extend plant life, prevent critical failures and reduce energy use. Tribosonics’ technology can be used in manufacturing, power generation and transport – for example to create smart factories, or in critical parts such as the bolts on wind turbines and the bearings within a ship’s propeller. The investment will allow the company to expand its 23-strong team with the addition of 10 new staff over the next 12 months, and invest further in product development. As part of the deal, Sarah Sandle who is VP Strategy of Rolls-Royce, joins the company as Chair. Tribosonics was founded by Dr Phil Harper, a specialist in tribology or the science of wear, friction and lubrication, and who is now the CTO. In 2018 he was joined by serial entrepreneur Glenn Fletcher, the CEO, who worked with him to develop and commercialise the company’s unique technology. Tribosonics has developed applications for a number of blue-chip clients. Glenn Fletcher said: “We are delighted to receive the backing of Mercia and NPIF. Mercia has a great track record in backing innovative tech companies. We are a proud Sheffield business, flying the flag for Northern innovation, cutting edge engineering, and transformational IOT solutions. “This investment will provide the resources to significantly enhance our technology platform and to expand our very talented team as we rapidly scale our commercial activities globally, using our unique sensing technology to create a more sustainable and valuable future.” Will Schaffer, Investment Manager at Mercia, added: “Tribosonics is at the forefront of Industry 4.0, allowing businesses to unlock data from industrial systems. The solutions that it is developing have huge potential to advance systems design, improve productivity and reduce costs. As friction accounts for 23% of global energy use, they often have the added benefit of reducing carbon emissions. The investment will help Tribosonics to accelerate product development and to deepen customer relationships.”; Ken Cooper, Managing Director at British Business Bank, said: “This investment demonstrates how NPIF is able to support high-growth businesses in the North, despite the difficulties of social distancing and uncertain economic times. Investment like this is providing vital funding to enable ambitious organisations to expand and create new job opportunities. With more businesses like Tribosonics able to take up investment we should see the economy in the north rebounding strongly.” The Northern Powerhouse Investment Fund project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.
sev22
16/9/2020
17:43
Canaccord Genuity reiterated their 'Buy' recommendation, issued on Monday the 14th of September 2020, with a new price target of 38p. https://www.sharecast.com/equity/Mercia_Technologies/broker-views
sev22
13/9/2020
16:20
Latest Tweet Mercia Asset Management PLC Retweeted 12th September, 2020. Whilst investing may have changed post-COVID, there are still plenty of opportunities out there, as we find out with Ken Cooper from @BritishBBank, @BevingtonRyan from @Maven_CP, Kate Ronayne from @longwallventure and Julian Viggars from @Mercia_PLC #highgrowth2020
sev22
09/9/2020
20:58
Spin-out raises £2.4m for early cancer detection test (9th September 2020). A university spin-out which has developed a way to detect cancer at an early stage using a simple blood test has completed a £2.4m funding round led by Mercia’s EIS funds. The investment will allow ClinSpec Diagnostics (ClinSpec Dx) to further develop its technology and expand its team. The Glasgow-based company was founded in 2016 to commercialise research by Dr Matthew Baker at the University of Strathclyde. Through a combination of infra-red light and artificial intelligence, its ‘drop, dry, detect’ technology provides results in minutes. Mercia first invested in the business in 2019. The latest round – which also includes funding from the Scottish Investment Bank, SIS Ventures, EOS Advisory and the University of Strathclyde – brings the total raised by the company so far to £4m. Studies have shown ClinSpec’s technology has potential as a multi-cancer early detection test which could also indicate the type and severity of the tumour, allowing doctors and clinicians to prioritise the most effective treatments. The new funding will allow it to complete its second brain cancer trial, develop an algorithm covering the most common cancers and create a further five jobs, taking its total headcount to 14. The company remains open for a further £1 million to prepare the groundwork for Series A funding. Mark Hegarty, CEO of ClinSpec Dx, said: “Worldwide, 26,000 people die from cancer each day. Early detection is critical for effective treatment, but many cancers go undetected for too long. This funding is another significant step forward for ClinSpec Dx in our mission to detect cancer earlier and help to increase patient survival and quality of life.”
sev22
Chat Pages: 50  49  48  47  46  45  44  43  42  41  40  39  Older
ADVFN Advertorial
Your Recent History
LSE
MERC
Mercia Ass..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211027 16:47:03